Skip to main content

Opus Genetics, Inc. (IRD)

Sector
Healthcare
Industry
Biotechnology
Last price
$4.05
As of

Kresmion compiles this page from IRD's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Opus Genetics, Inc. (IRD): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-10.

As of . Source: SEC EDGAR filings for IRD. Method and limitations.

COMPANY DOSSIER

See the full IRD dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for IRD on one page. Preview it with sample data, then open it live with a free account.

Preview the IRD dossier

Active events for IRD

FREE, NO ACCOUNT

Every event on IRD, as it fires

You are seeing 5 of 10 events recorded on IRD since 2026-05-30.

The five above landed across 3 days. The other 5 were recorded on 2 other days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.

Recent SEC filings, IRD

More data on IRD

IRD against its peers

IRD's operating margin of -271.9% ranks in the 46th percentile of 13 Biotechnology sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.

MetricIRDPeer medianPercentilen
Revenue FY14.2M USD44.6M USD3213
Operating margin-271.9%-212.9%4613
Net margin-349.3%-203.3%3913
Return on equity-323.1%-45.7%1318
1 year117.2%-23.2%9820

Peers (21): CTNM, ALEC, MPLT, PEPG, CRMD, PBYI, CYDY, CCCC, SPRY, FENC, TECX, INDP, OCS, RZLT, PRTA, LYEL, AVTX, YDES, ASMB, CTMX, PHAT. Left out: ASPE (no annual filing), PRTCY (period gap), TRXB (no annual filing), BLSM (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (IRD: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Cite this data

Kresmion counts the managers it follows that reported a non-option position in IRD on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on IRD in the last 180 days.

Upstream: SEC EDGAR filings for IRD

Kresmion, "Opus Genetics, Inc. (IRD) institutional holdings and SEC filings", data as of 2026-11-17, https://kresmion.com/research/IRD. Upstream data: SEC EDGAR filings for IRD.

Link to this data (HTML):

<a href="https://kresmion.com/research/IRD">Opus Genetics, Inc. (IRD) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow IRD on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to IRD for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the IRD dossier
Share

The IRD intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.